학술논문
Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype
Document Type
Article
Author
Source
In Clinical Immunology August 2018 193:24-32
Subject
Language
ISSN
1521-6616